Search

everythinglearnresearchcommunity

for

Search:↓

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Bimekizumab can improve scarring alopecia in severe psoriasis.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Apremilast showed mixed results for treating severe alopecia areata.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Dutasteride may become the top choice for treating hair loss.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The committee decided not to approve the drug due to low effectiveness and high risks.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Suppressing ODC activity reduces tumor growth in hair follicles.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Dystonia may be part of PAS-4 and linked to immune issues.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Dutasteride effectively and safely treats male hair loss for over a year.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Tridax procumbens plant parts boost immune response in mice.